ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 191 filers reported holding ARGENX SE in Q1 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $524,569 | -24.3% | 1,067 | -40.0% | 0.24% | -23.3% |
| Q2 2023 | $692,940 | -20.3% | 1,778 | -23.8% | 0.32% | -55.2% |
| Q1 2023 | $869,229 | -1.6% | 2,333 | 0.0% | 0.71% | +34.9% |
| Q4 2022 | $883,810 | +8.0% | 2,333 | +0.6% | 0.52% | +12.4% |
| Q3 2022 | $818,000 | +0.2% | 2,318 | +7.7% | 0.47% | -5.3% |
| Q2 2022 | $816,000 | -15.4% | 2,153 | -29.7% | 0.49% | -19.7% |
| Q1 2022 | $965,000 | -50.5% | 3,061 | -45.0% | 0.61% | -60.4% |
| Q4 2021 | $1,948,000 | +73.9% | 5,562 | +50.0% | 1.55% | +109.3% |
| Q3 2021 | $1,120,000 | +27.4% | 3,707 | +27.0% | 0.74% | +18.9% |
| Q2 2021 | $879,000 | +35.4% | 2,919 | +23.8% | 0.62% | +29.3% |
| Q1 2021 | $649,000 | -20.7% | 2,357 | -15.3% | 0.48% | -7.7% |
| Q4 2020 | $818,000 | +51.5% | 2,783 | +35.2% | 0.52% | +32.5% |
| Q3 2020 | $540,000 | +28.0% | 2,058 | +9.9% | 0.39% | +12.9% |
| Q2 2020 | $422,000 | – | 1,872 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |